Geneva University Hospitals, ED
Geneva, 1211, Switzerland
NCT Number: NCT02980081
There are only few recognized indications for the realization of plain abdominal X-rays in the emergency departement.
The objective of this study is to explore the reasons for abdominal plain X-rays prescription in the Emergency departments (EDs) of two hospitals.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Geneva, 1211, Switzerland
All abdominal plain x-rays prescription will be reviewed in order to identify reasons for prescribing this exam. The indications will be compared to international guidelines in order to identify whether abdominal plain x-rays are overprescribed. Reasons for overprescription will be identify by chart review.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Abdominal plain x-ray as prescribed by the emergency physician
Time frame: Within 24 hours after ED admission
Identification of the indications for abdominal plain x-ray and of the number of patients with appropriate indications accordingly to international guidelines
Time frame: Within 24 hours after ED admission
Describe whether other radiological exams (CT, ultrasonography, MRI) have been performed and their indications.
University Hospital, Geneva
Other
Abdominal Plain X-ray in the Emergency Departement: Really Usefull?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06160778
Abdomen, Acute, Abdominal Pain
Calgary, Alberta, Canada
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial DetailsNCT04916028
Chemically-Induced Disorders, Disease Attributes
Amiens, France
View Trial DetailsNCT04031183
Disease Attributes, Emergencies
Angers, France
View Trial Details